|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2000-9-20
|
|
pubmed:abstractText |
Although previous studies have shown that dysthymia, or chronic depression, commonly responds to antidepressant medications (with improvements in depressive symptoms and psychosocial functioning), there have been no systematic studies of the impact of antidepressant treatment on personality variables in patients with this disorder.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0002-953X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
157
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1436-44
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10964860-Adult,
pubmed-meshheading:10964860-Age of Onset,
pubmed-meshheading:10964860-Antidepressive Agents, Tricyclic,
pubmed-meshheading:10964860-Double-Blind Method,
pubmed-meshheading:10964860-Dysthymic Disorder,
pubmed-meshheading:10964860-Factor Analysis, Statistical,
pubmed-meshheading:10964860-Female,
pubmed-meshheading:10964860-Humans,
pubmed-meshheading:10964860-Imipramine,
pubmed-meshheading:10964860-Male,
pubmed-meshheading:10964860-Personality,
pubmed-meshheading:10964860-Personality Inventory,
pubmed-meshheading:10964860-Placebos,
pubmed-meshheading:10964860-Serotonin Uptake Inhibitors,
pubmed-meshheading:10964860-Sertraline,
pubmed-meshheading:10964860-Social Adjustment,
pubmed-meshheading:10964860-Temperament,
pubmed-meshheading:10964860-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality.
|
|
pubmed:affiliation |
Outpatient Mental Health Services, Beth Israel Medical Center, New York, NY 10003, USA. dhellerstein@bethisraelny.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
